首页|Analysis on medication rule of traditional Chinese medicine treating chemotherapy-induced diarrhea based on traditional Chinese medicine(TCM) inheritance computing platform system

Analysis on medication rule of traditional Chinese medicine treating chemotherapy-induced diarrhea based on traditional Chinese medicine(TCM) inheritance computing platform system

扫码查看
原文链接
  • NETL
  • NSTL
  • 维普
  • 万方数据
Objective: To dig deeper into the traditional Chinese medicine treatment rules of chemotherapy-induced diarrhea with traditional Chinese medicine (TCM) inheritance computing platform system. Methods: Taking "traditional Chinese medicine", "chemotherapy" and "diarrhea" as the theme words, comprehensive search of the database of CNKI, Wanfang and VIP from its inception to November 2020 was conduct-ed. The formulas of external treatment of traditional Chinese medicine for chemotherapy-induced diarrhea were included and the association rule, clustering and factor analysis were carried out. Results: A total of 145 papers, 57 prescriptions meeting the inclusion criteria were collected, among which high-frequency drugs including Baizhu (Atractylodis macrocephalae rhizoma), Fuling (Poria), Dangshen (Codonopsisradix), Huanglian (Coptidis rhizoma), Zhigancao (Glycyrrhizae radix et rhizoma praeparata cum melle) were the most commonly used. The confidence level was set as 0.7 and the support level was set as 10, 12 core compatibility groups were obtained, and 6 categories were cluster analyzed. Conclusion: The principle of external treatment of chemotherapy-induced diarrhea is mainly "restore deficiency and benefiting qi", "benefiting water infiltration and dampness", "clearing heat" and "inducing astringency". Prescription combination and new prescription combination based on traditional Chinese medicine (TCM) inheritance computing platform system can be used as reference for clinicians and applied in primary hospitals.

Chemotherapy induced diarrheaTraditional Chinese medicineMedication regulationData miningTraditional Chinese medicine(TCM) inheritance computing platform system

Yu Gao、Shao-Bo Hu、Chao Deng、Fei Su、Li-Qun Jia

展开 >

Graduate School,Beijing University of Chinese Medicine,Beijing 100029,China

Department of Oncology of Integrated Chinese and Western Medicine,China-Japan Friendship Hospital,Beijing 100029,China

国家自然科学基金青年基金Capital Health Development Scientific Research ProjectState Administration of Traditional Chinese Medicine Clinical Collaboration Project of TCM and Western Medicine for Major and InIn-Hospital Project of China-Japan Friendship Hospital

81904001first issue 2018-1-40612019-ZX-0052019-1-QN-56

2022

海南医科大学学报(英文版)

海南医科大学学报(英文版)

ISSN：
年,卷(期)：2022.28(7)
  • 9